Zoetis Current Ratio 2011-2018 | ZTS

Current and historical current ratio for Zoetis (ZTS) from 2011 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Zoetis current ratio for the three months ending December 31, 2018 was 3.60.
Zoetis Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $4.40B $1.22B 3.60
2018-09-30 $4.08B $1.00B 4.06
2018-06-30 $4.24B $0.97B 4.38
2018-03-31 $4.27B $1.00B 4.27
2017-12-31 $4.22B $1.09B 3.86
2017-09-30 $4.89B $1.75B 2.80
2017-06-30 $3.58B $1.78B 2.01
2017-03-31 $3.38B $1.73B 1.96
2016-12-31 $3.39B $1.12B 3.04
2016-09-30 $3.36B $1.04B 3.24
2016-06-30 $3.33B $1.04B 3.20
2016-03-31 $3.31B $1.16B 2.84
2015-12-31 $3.83B $1.78B 2.15
2015-09-30 $3.45B $1.66B 2.08
2015-06-30 $3.32B $1.57B 2.11
2015-03-31 $3.11B $1.37B 2.27
2014-12-31 $3.47B $1.09B 3.19
2014-09-30 $3.35B $1.00B 3.36
2014-06-30 $3.33B $1.06B 3.14
2014-03-31 $3.22B $1.13B 2.86
2013-12-31 $3.36B $1.42B 2.37
2013-09-30 $3.08B $1.31B 2.36
2013-06-30 $3.08B $1.32B 2.33
2013-03-31 $2.94B $1.29B 2.29
2012-12-31 $2.86B $1.12B 2.55
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $2.31B $0.84B 2.74
2010-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $48.449B $5.825B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $28.732B 10.63
Grifols (GRFS) Spain $13.029B 15.92
Ionis Pharmaceuticals (IONS) United States $10.149B 31.47
Sage Therapeutics (SAGE) United States $7.745B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.384B 10.57
Neurocrine Biosciences (NBIX) United States $7.222B 465.47
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.420B 8.65
Tilray (TLRY) United States $4.965B 0.00
United Therapeutics (UTHR) United States $4.525B 7.70
Taro Pharmaceutical Industries (TARO) Israel $4.215B 13.57
FibroGen (FGEN) United States $4.055B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.722B 0.00
Portola Pharmaceuticals (PTLA) United States $2.432B 0.00
PTC Therapeutics (PTCT) United States $2.163B 0.00
USANA Health Sciences (USNA) United States $1.904B 15.97
Ironwood Pharmaceuticals (IRWD) United States $1.846B 0.00
Heron Therapeutics (HRTX) United States $1.840B 0.00
Xencor (XNCR) United States $1.792B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.784B 0.00
Aerie Pharmaceuticals (AERI) United States $1.783B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.696B 21.12
Endo (ENDP) Ireland $1.674B 2.58
Pacira Pharmaceuticals (PCRX) United States $1.665B 144.00
Madrigal Pharmaceuticals (MDGL) United States $1.637B 0.00
Zogenix (ZGNX) United States $1.614B 0.00
Corcept Therapeutics (CORT) United States $1.407B 20.43
Tricida (TCDA) United States $1.393B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.303B 0.00
Esperion Therapeutics (ESPR) United States $1.128B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.057B 0.00
TherapeuticsMD (TXMD) United States $0.989B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.881B 0.00
CannTrust Holdings (CTST) Canada $0.799B 0.00
Akebia Therapeutics (AKBA) United States $0.752B 0.00
ChemoCentryx (CCXI) United States $0.733B 0.00
ArQule (ARQL) United States $0.693B 0.00
Odonate Therapeutics (ODT) United States $0.618B 0.00
Dermira (DERM) United States $0.593B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.582B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.571B 0.00
Forty Seven (FTSV) United States $0.561B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.554B 0.00
GlycoMimetics (GLYC) United States $0.550B 0.00
Collegium Pharmaceutical (COLL) United States $0.483B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.469B 24.21
Corbus Pharmaceuticals Holdings (CRBP) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.429B 0.00
Translate Bio (TBIO) United States $0.426B 0.00
Flexion Therapeutics (FLXN) United States $0.416B 0.00
KalVista Pharmaceuticals (KALV) United States $0.414B 0.00
OptiNose (OPTN) United States $0.410B 0.00
Aptorum Group (APM) China $0.399B 0.00
TCR2 THERAPTCS (TCRR) United States $0.388B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 0.00
Mast Therapeutics (SVRA) United States $0.370B 0.00
ImmunoGen (IMGN) United States $0.363B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Karyopharm Therapeutics (KPTI) United States $0.296B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.291B 0.00
Minerva Neurosciences (NERV) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.282B 2.62
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.277B 10.26
Harpoon Therapy (HARP) United States $0.273B 0.00
Aclaris Therapeutics (ACRS) United States $0.264B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.257B 0.00
Xeris Pharmaceuticals (XERS) United States $0.249B 0.00
Calithera Biosciences (CALA) United States $0.247B 0.00
Dova Pharmaceuticals (DOVA) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.234B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.234B 0.00
Concert Pharmaceuticals (CNCE) United States $0.225B 0.00
Aldeyra Therapeutics (ALDX) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.221B 0.00
Rafael Holdings (RFL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.218B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
Opexa Therapeutics (ACER) United States $0.201B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Majesco Entertainment (PTE) United States $0.186B 0.00
Recro Pharma (REPH) United States $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 185.60
AgeX Therapeutics (AGE) United States $0.177B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
ElectroCore (ECOR) United States $0.173B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Ocular Therapeutix (OCUL) United States $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.167B 0.00
Neon Therapeutics (NTGN) United States $0.166B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Tyme Technologies (TYME) United States $0.154B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.143B 0.00
MediWound (MDWD) Israel $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.134B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Iterum Therapeutics (ITRM) Ireland $0.113B 0.00
China SXT Pharmaceuticals (SXTC) China $0.113B 0.00
Neos Therapeutics (NEOS) United States $0.111B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
Natural Alternatives (NAII) United States $0.097B 9.46
Adamis Pharmaceuticals (ADMP) United States $0.093B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
DURECT (DRRX) United States $0.092B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.090B 0.00
Nivalis Therapeutics (ALPN) United States $0.090B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Zafgen (ZFGN) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.088B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.076B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.059B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.047B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.042B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Shineco (TYHT) China $0.030B 5.08
HANCOCK JAFFE (HJLI) United States $0.029B 0.00
IsoRay (ISR) United States $0.028B 0.00
Achieve Life Sciences (ACHV) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.38
PharmAthene (ALT) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Xenetic Biosciences (XBIO) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.87
PRECISION THERAPEUTICS INC (AIPT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Achaogen (AKAO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00